Delivery Order SPE2DB22D3501-SPE2DB25FXD28
- Not listed
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.52 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract involves the delivery of a corticosteroid medication commonly utilized across military and federal...
- The Defense Logistics Agency awarded a $2,619.29 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexamethasone 10 mg/mL vials. This competitively awarded, firm fixed-price delivery order is set to conclude on August 13, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,113.35 for 100 tablets of Dexamethasone 4 mg, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, employs firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,343.25. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,911,624 units of Dexamethasone 20 mg/5 ml vials, a critical medication. The order has a firm fixed price of $5,562.90 and a completion date of September 24, 2024. Amerisourcebergen, through its extensive pharmaceutical supply chain, will provide this medication to support various military treatment...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dexamethasone 10 mg/mL vials, a corticosteroid medication, with a ceiling value of $1,971.80 and a completion date of January 29, 2025. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,837.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 0.5 mg/5 mL elixir (237 mL), with an ultimate completion date of August 11, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,188.80 firm fixed-price delivery order is for the supply of 4566401459 dexamethasone 10 mg/ml vials, with a completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXD28Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dexamethasone 10 mg/ml vials with a ceiling value of $4,116.72 and a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, will deliver this corticosteroid medication to support military and defense health system requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Through this flexible contract mechanism, AmerisourceBergen Drug Corp fulfills medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/3/25 |